1 active not recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
Follow CXR: new trials by email Literature Review of CXR trials Research Report on CXR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis Pre-operative abemaciclib, Device for Cerebral Fluid Dialysate Collection, Ashion Analytics GEM ExTra - Glioma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 5 | 2023-04-07 | 2026-10-06 |
| T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers IL-2 (Aldesleukin), Cyclophosphamide, KK-LC-1 TCR - Kita-kyushu Lung Cancer Antigen 1, Human | Phase 1 | Terminated | National Cancer Institute (NCI) | 36 | 2022-03-08 | 2025-12-02 |
Brain Neoplasms (1) · Carcinoma (1) · Glioma (1) · Neoplasm Metastasis (1) · Triple Negative Breast Neoplasms (1)
National Cancer Institute (NCI) (2)
United States (2)
Sadhana Jackson, M.D. (1) · Scott M Norberg, D.O. (1)